Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Better protection for the neonatal brain

22.11.2006
Around one in ten children is born preterm. The brain is particularly vulnerable in preterm infants. Insults during this time of brain development can subsequently lead to motor deficits, cognitive limitations, attention deficits, learning difficulties and even severe disabilities.

Within the EU project NEOBRAIN (Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants), scientists will collaborate in order to identify strategies to diagnose and to protect the newborn brain against such insults.

International partners

In NEOBRAIN, small and medium enterprises collaborate with academic research groups. The project links scientists from a total of 13 partner institutions. The involvement of the companies provides a unique opportunity for using the research results in product development without delay. Publication of project findings in high-profile journals will disseminate new research results and resulting applications on an international level. Scientific coordinator for the entire EU project NEOBRAIN is Prof. Dr. Olaf Dammann from Hannover Medical School, Germany. Patent research and press information will be coordinated in Innsbruck.

Name of participating organisation (Short name,City, Country)
Medizinische Hochschule Hannover (MHH, Hannover, Germany)
BIOCRATES life sciences GmbH Innsbruck (BIOCRATES, Innsbruck, Austria)
BrainZ (BrainZ, Auckland, New Zealand)
Bioanalyt GmbH (BIOANALYT, Potsdam, Germany)
THERAPTOSIS S.A. (THERAPTOSIS, Paris, France)
NEUROPHARMA (NEUROPHARMA, Madrid, Spain)
University Medical Center Utrecht (UMCU, Utrecht, Netherlands)
Göteborgs universitet (UGOT, Gothenborg, Sweden)
Institut National de la santé et de la Recherche Médicale (INSERM, Paris, France)
Université de Genève-Hôpitaux Universitaires de Genève (UNIGE, Geneva, Switzerland)
Charité Universitätsmedizin Berlin (CHARITÉ, Berlin, Germany)
Università degli Studi di Siena (UNISI, Siena, Italy)
Lunds Universitet (ULUND, Lund, Sweden)
Economic impact
Medical progress has reduced infant death considerably. This also means that the number of preterm babies that survive is rising steadily. Of the roughly four million live births per year within the EU, 40,000 preterm babies are at highest for brain damage. Almost half the individuals with cerebral palsy (41 percent) are born preterm.

In addition to the worry for parents and relatives of prematurely born children, the increasing number of premature babies also has economic effects: across the EU, between six and seven billion euros per year are spent on treating premature babies. It is not possible to apply the results of medical research obtained in adults reliably to premature babies. Therefore the medical profession faces the problem that not only is there no marker for early diagnosis of brain damage, there is also no prophylaxis or therapy that protects the brain.

New approaches in research

It is precisely at this point that the NEOBRAIN comes in. The EU research project, which runs for three years, aims to:

1. find biomarkers for early brain damage. In various animal tests the mechanisms leading to brain damage will be investigated. Moreover, a clinical study of children born before the 28th week of pregnancy is planned in order to develop marker profiles.

2. develop strategies for protecting the brain. Here too animal tests will be carried out. Only the most promising results will find their way into clinical research.

3. create a clinical platform as research network for future European and international studies.

4. develop medication within the three year project period and beyond.

The results of neonatal basic research will thus feed directly into clinical research. New findings and therapeutic approaches gained in this way will be introduced rapidly into clinical practice in neonatal intensive care.

NEOBRAIN budget
- project volume 4.4 million euros
- grant volume 3.3 million euros

Mag. Uwe Steger | alfa
Further information:
http://www.neobrain.eu

More articles from Health and Medicine:

nachricht Speed data for the brain’s navigation system
06.12.2016 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>